Increased Rates of Purpureocillium lilacinum Mold among Laboratory Culture Results, United States
- PMID: 41017071
- PMCID: PMC12483104
- DOI: 10.3201/eid3110.250715
Increased Rates of Purpureocillium lilacinum Mold among Laboratory Culture Results, United States
Abstract
Purpureocillium lilacinum, a common environmental mold and bionematicide, can cause human infections. At a major US commercial laboratory during March 2019-February 2025, P. lilacinum culture rates increased; rates were highest in the South Atlantic and Pacific states. Nonculture-based diagnostic tools such as microscopy may help identify and confirm clinical infection earlier.
Keywords: Purpureocillium; United States; fungi; hyalohyphomycosis; laboratories; mold.
Figures
References
-
- Sprute R, Salmanton-García J, Sal E, Malaj X, Ráčil Z, Ruiz de Alegría Puig C, et al. ; FungiScope® ECMM/ISHAM Working Group. Invasive infections with Purpureocillium lilacinum: clinical characteristics and outcome of 101 cases from FungiScope® and the literature. J Antimicrob Chemother. 2021;76:1593–603. 10.1093/jac/dkab039 - DOI - PMC - PubMed
-
- US Environmental Protection Agency. Registration decision for the new active ingredient Purpureocillium lilacinum strain PL11 [cited 2025 Apr 1]. https://www.regulations.gov/document/EPA-HQ-OPP-2016-0079-0013
-
- US Environmental Protection Agency. Paecilomyces species PC Codes 115002, 028826, and 115003 Interim registration review decision case number 6047 [cited 2025 Apr 1]. https://www.regulations.gov/document/EPA-HQ-OPP-2012-0403-0011
-
- Centers for Disease Control and Prevention. Reportable fungal diseases by state [cited 2025 Sep 12]. https://www.cdc.gov/fungal/php/case-reporting/index.html
MeSH terms
LinkOut - more resources
Full Text Sources
Medical